|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Deferred Offering Costs | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | ||||||||
| Accounts receivable | ||||||||
| Prepaid expenses | ||||||||
| Receivable from Related Party | ||||||||
| Total Current Assets | ||||||||
| Prepaid expenses – non-current | ||||||||
| Investments held in Trust Account | ||||||||
| TOTAL ASSETS | ||||||||
| LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS' DEFICIT | ||||||||
| Current liabilities: | ||||||||
| Accrued costs and expenses | ||||||||
| Accounts payable and accrued expenses | ||||||||
| Promissory note – related party | ||||||||
| Due to related party | ||||||||
| Income Tax Payable | ||||||||
| Total Current Liabilities | ||||||||
| Warrant liabilities | ||||||||
| Deferred Underwriters' discount | ||||||||
| Total Liabilities | ||||||||
| Commitments and Contingencies (Note 6) | ||||||||
| Class A ordinary shares subject to possible redemption, 34,500,000 shares and no shares at redemption value, at December 31, 2022 and 2021, respectively | ||||||||
| Common Class A | ||||||||
| Total class A ordinary shares subject to possible redemption, 34,500,000 shares and no shares at redemption value, at December 31, 2022 and 2021, respectively | ||||||||
| Shareholders' Deficit | ||||||||
| Preference shares, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding at December 31, 2022 and 2021 | ||||||||
| Common stock value | ||||||||
| Common Class A | ||||||||
| Common Class B | ||||||||
| Additional paid-in capital | ||||||||
| Accumulated deficit | ||||||||
| Total shareholders' deficit | ||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT |
Loading...
